Press Releases from DelveInsight Business Research LLP (2529 total)
Relapsed/Refractory Acute Myeloid Leukemia Pipeline Outlook Report 2024
DelveInsight's, "Relapsed/refractory acute myeloid leukemia (AML) Pipeline Insight, 2024" report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Relapsed/refractory acute myeloid leukemia (AML) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Relapsed/Refractory…
Refractory Multiple Myeloma Pipeline Outlook Report 2024
elveInsight's, "Refractory Multiple Myeloma Pipeline Insight, 2024," report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Refractory Multiple Myeloma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Refractory Multiple Myeloma Pipeline Report
• DelveInsight's…
The Market share for VX15 (Pepinemab) by Vaccinex, Inc. Set to Experience Tremen …
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on VX15 (Pepinemab) (Vaccinex, Inc.) providing insights into the drug market landscape and market forecast of VX15 (Pepinemab) upto 2032. The report, titled "VX15 (pepinemab) Market Size, Forecast, and Emerging Insight - 2032" is now available for review and analysis.
Are you interested in finding out the projected market size of VX15 (Pepinemab)…
Giredestrant by Genentech expected to drive market size of ER+ve HER2-ve Breast …
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Giredestrant (Genentech) providing insights into the drug market landscape and market forecast of Giredestrant upto 2032. The report, titled "Giredestrant Market Size, Forecast, and Emerging Insight - 2032" is now available for review and analysis.
Are you interested in finding out the projected market size of Giredestrant in 2032? Giredestrant Market Forecast
https://www.delveinsight.com/report-store/giredestrant-emerging-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
…
Chronic Liver Disease Market to Show a Rise During the Study Period | Abbott Lab …
DelveInsight's "Chronic Liver Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Liver Disease, historical and forecasted epidemiology as well as the Chronic Liver Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Chronic Liver Disease market report provides current treatment practices, emerging drugs, Chronic Liver Disease market share of the individual therapies, and current…
Clear Cell Carcinoma Market to Show a Rise During the Study Period |F. Hoffmann- …
DelveInsight's "Clear Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Clear Cell Carcinoma, historical and forecasted epidemiology as well as the Clear Cell Carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Clear Cell Carcinoma market report provides current treatment practices, emerging drugs, Clear Cell Carcinoma market share of the individual therapies, and current…
CNS Lymphoma Market to Show a Rise During the Study Period | Shandong New Time P …
DelveInsight's "CNS Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the CNS Lymphoma, historical and forecasted epidemiology as well as the CNS Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The CNS Lymphoma market report provides current treatment practices, emerging drugs, CNS Lymphoma market share of the individual therapies, and current and forecasted CNS Lymphoma market…
Community-Acquired Bacterial Pneumonia Market to Show a Rise During the Study Pe …
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Chronic Hemodialysis Market to Show a Rise During the Study Period | Fresenius M …
DelveInsight's "Chronic Hemodialysis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Hemodialysis, historical and forecasted epidemiology as well as the Chronic Hemodialysis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Chronic Hemodialysis market report provides current treatment practices, emerging drugs, Chronic Hemodialysis market share of the individual therapies, and current and forecasted Chronic Hemodialysis market…
Chronic Brain Damage Market to Show a Rise During the Study Period | NeuroVive P …
DelveInsight's "Chronic Brain Damage Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Brain Damage, historical and forecasted epidemiology as well as the Chronic Brain Damage market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Chronic Brain Damage market report provides current treatment practices, emerging drugs, Chronic Brain Damage market share of the individual therapies, and current…
Pancreatic Ductal Adenocarcinoma Pipeline Outlook Report 2024 | Alligator Biosci …
DelveInsight's, "Pancreatic Ductal Adenocarcinoma Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Pancreatic Ductal Adenocarcinoma pipeline landscape. It covers the Pancreatic Ductal Adenocarcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Pancreatic Ductal Adenocarcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key…
Osteoarthritis Pipeline Outlook Report 2024 | Biosplice Therapeutics, Gilead Sci …
DelveInsight's, "Osteoarthritis Pipeline Insight 2024" report provides comprehensive insights about 130+ companies and 130+ pipeline drugs in the Osteoarthritis pipeline landscape. It covers the Osteoarthritis pipeline drug profiles, including Osteoarthritis clinical trials and nonclinical stage products. It also covers the Osteoarthritis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Osteoarthritis Pipeline…
Ocular Hypertension Pipeline Outlook Report 2024 | Nicox, Qlaris Bio, TheratOcul …
DelveInsight's, "Ocular Hypertension Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Ocular Hypertension pipeline landscape. It covers the Ocular Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Ocular Hypertension pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Obesity Pipeline Outlook Report 2024 | Aardvark Therapeutics, Adocia, Agentix, A …
DelveInsight's, "Obesity Pipeline Insight 2024" report provides comprehensive insights about 100+ Obesity companies and 130+ Obesity pipeline drugs in the Obesity pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Obesity therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Obesity pipeline products in this space.
Key Takeaways from the Obesity Pipeline Report
• DelveInsight's Obesity…
Non Alcoholic Fatty Liver Disease Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Non-Alcoholic Fatty Liver Disease Pipeline Insight 2023" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Non-Alcoholic Fatty Liver Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Non-Alcoholic…
NK Cell Therapy Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "NK Cell Therapy Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 185+ pipeline drugs in NK Cell Therapy pipeline landscape. It covers the NK Cell Therapy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the NK Cell Therapy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key…
Myelodysplastic Syndrome Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the Myelodysplastic Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelodysplastic Syndrome pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Myelodysplastic…
Multiple Sclerosis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Multiple Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Multiple sclerosis pipeline landscape. It covers the Multiple Sclerosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Multiple Sclerosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Multiple Myeloma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Multiple Myeloma Pipeline Insights 2024" report provides comprehensive insights about 75+ Multiple Myeloma Companies and 80+ pipeline drugs in the Multiple Myeloma pipeline landscape. It covers the Multiple Myeloma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Multiple Myeloma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from…
Metastatic Melanoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Metastatic Melanoma Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Metastatic Melanoma pipeline landscape. It covers the Metastatic Melanoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Melanoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Metastatic Colorectal Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Metastatic Colorectal Cancer Pipeline Insight 2024" report provides comprehensive insights about 130+ companies and 140+ pipeline drugs in the Metastatic Colorectal Cancer pipeline landscape. It covers the Metastatic Colorectal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Colorectal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Metastatic Castration-Resistant Prostate cancer Pipeline Outlook Report 2024 (Up …
DelveInsight's, "Metastatic Castration-Resistant Prostate Cancer Pipeline Insight 2023" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Metastatic Castration-Resistant Prostate Cancer pipeline landscape. It covers the Metastatic Castration-Resistant Prostate Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Castration-Resistant Prostate Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline…
Metastatic Breast Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Metastatic Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Metastatic Breast Cancer pipeline landscape. It covers the Metastatic Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Metastatic Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Major Depressive Disorder Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Major Depressive Disorder Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Major Depressive Disorder pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Liver Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Liver Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Liver Cancer pipeline landscape. It covers the Liver Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Liver Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Liver…
Influenza Pipeline Outlook, Clinical Trials, and Emerging Therapies Report 2024
The Influenza Pipeline Insight 2024 report by DelveInsight offers a thorough global overview of Influenza treatments, including those already in the market, as well as those in different phases of clinical development. Prominent pharmaceutical firms are dedicated to progressing the pipeline landscape and fostering the potential growth of Influenza therapeutic advancements.
Key Takeaways from the Influenza Pipeline Report
• DelveInsight's Influenza pipeline report depicts a robust space with 120+ active players working…
Idiopathic Pulmonary Fibrosis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Idiopathic Pulmonary Fibrosis pipeline landscape. It covers the Idiopathic Pulmonary Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Idiopathic Pulmonary Fibrosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Hypertension Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hypertension Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Hypertension pipeline landscape. It covers the Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hypertension pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Hypertension Pipeline Report
• DelveInsight's Hypertension…
HER2-Negative Breast Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "HER2-Negative Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the HER2-Negative Breast Cancer pipeline landscape. It covers the HER2-Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the HER2-Negative Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Hepatocellular Carcinoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatocellular Carcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Hepatocellular…
Hepatitis B Virus Infection Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hepatitis B Virus Infection Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Hepatitis B Virus Infection pipeline landscape. It covers the Hepatitis B Virus Infection pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatitis B Virus Infection pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products…
Hemophilia Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hemophilia Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Hemophilia Pipeline Report
• DelveInsight's Hemophilia pipeline…
Head and Neck Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Head and Neck Cancer Pipeline Insight, 2024," report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Head and Neck cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Head and Neck…
DDR Defective Tumors Market Report 2032 | DelveInsight
DelveInsight's "DDR Defective Tumors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the DDR Defective Tumors, historical and forecasted epidemiology as well as the DDR Defective Tumors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The DDR Defective Tumors market report provides current treatment practices, emerging drugs, DDR Defective Tumors market share of the individual therapies, and current…
Invasive Pneumococcal Disease Market to Show a Rise, asserts DelveInsight | Phar …
DelveInsight's "Invasive Pneumococcal Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Invasive Pneumococcal Disease, historical and forecasted epidemiology as well as the Invasive Pneumococcal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Invasive Pneumococcal Disease market report provides current treatment practices, emerging drugs, Invasive Pneumococcal Disease market share of the individual therapies, and current…
Primary Myelofibrosis Market to Show a Rise, asserts DelveInsight | Pharma giant …
DelveInsight's "Primary Myelofibrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Primary Myelofibrosis, historical and forecasted epidemiology as well as the Primary Myelofibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Primary Myelofibrosis market report provides current treatment practices, emerging drugs, Primary Myelofibrosis market share of the individual therapies, and current and forecasted Primary Myelofibrosis market…
Positive Air Pressure Device Market Insights by DelveInsight | Prominent pharmac …
"DelveInsight's 'Positive Air Pressure Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Positive Air Pressure Devices and the historical and forecasted Positive Air Pressure Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Request for a sample copy of the Positive Air Pressure Device Market report @ https://www.delveinsight.com/sample-request/positive-air-pressure-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
The Positive Air Pressure Device market report offers an overview of the Positive…
Ladarixin Market Size expected to increase many folds by 2032, reports DelveInsi …
[Las Vegas, United States] (21th March 2024) The Latest report, LADARIXIN Market Size, Forecast, and Drug Insight 2032 is published by DelveInsight, a leader in healthcare research firm, providing insights into the LADARIXIN market landscape and market forecast of LADARIXIN up to 2032. This report is now available for review and analysis.
Are you interested in finding out the projected market size of LADARIXIN in 2032? Click @ LADARIXIN Market Size-…
TRESIBA Market Size expected to increase many folds by 2032, reports DelveInsigh …
[Las Vegas, United States] (21th March 2024) The Latest report, TRESIBA Market Size, Forecast, and Drug Insight 2032 is published by DelveInsight, a leader in healthcare research firm, providing insights into the TRESIBA market landscape and market forecast of TRESIBA up to 2032. This report is now available for review and analysis.
Are you interested in finding out the projected market size of TRESIBA in 2032? Click @ TRESIBA Market Size-…
TOUJEO Market Size expected to increase many folds by 2032, reports DelveInsight
[Las Vegas, United States] (21th March 2024) The Latest report, TOUJEO Market Size, Forecast, and Drug Insight 2032 is published by DelveInsight, a leader in healthcare research firm, providing insights into the TOUJEO market landscape and market forecast of TOUJEO up to 2032. This report is now available for review and analysis.
Are you interested in finding out the projected market size of TOUJEO in 2032? Click @ TOUJEO Market Size-…
AFREZZA Market Size expected to increase many folds by 2032, reports DelveInsigh …
[Las Vegas, United States] (4th March 2024) The Latest report, AFREZZA Market Size, Forecast, and Drug Insight 2032 is published by DelveInsight, a leader in healthcare research firm, providing insights into the AFREZZA market landscape and market forecast of AFREZZA up to 2032. This report is now available for review and analysis.
Are you interested in finding out the projected market size of AFREZZA in 2032? Click @ AFREZZA Market Size-…
FIASP Market Size expected to increase many folds by 2032, reports DelveInsight
[Las Vegas, United States] (4th March 2024) The Latest report, FIASP Market Size, Forecast, and Drug Insight 2032 is published by DelveInsight, a leader in healthcare research firm, providing insights into the FIASP market landscape and market forecast of FIASP up to 2032. This report is now available for review and analysis.
Are you interested in finding out the projected market size of FIASP in 2032? Click @ FIASP Market Size-…
Exosomes Pipeline Outlook Report 2024 | Capricor Therapeutics, Direct Biologics, …
DelveInsight's, "Exosomes Pipeline Insight 2024" report provides comprehensive insights about 60+ companies and 110+ pipeline drugs in the Exosomes pipeline landscape. It covers the Exosomes pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Exosomes pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Exosomes Pipeline Report
• DelveInsight's Exosomes…
Esophageal Cancer Pipeline Outlook Report 2024 | BeiGene, AstraZeneca, CSPC Zhon …
DelveInsight's, "Esophageal Cancer Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Esophageal Cancer pipeline landscape. It covers the Esophageal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Esophageal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Eczema Pipeline Outlook Report 2024 | LEO Pharma, GlaxoSmithKline, Arjil Pharmac …
DelveInsight's, "Eczema Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Eczema pipeline landscape. It covers the Eczema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Eczema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Eczema Pipeline Report
• DelveInsight's Eczema pipeline…
Duchenne Muscular Dystrophy Pipeline Outlook Report 2024
DelveInsight's, "Duchenne Muscular Dystrophy Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including Duchenne Muscular Dystrophy clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
…
Dry Age-Related Macular Degeneration Pipeline Outlook Report 2024
DelveInsight's, "Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2024" report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Dry Age-related Macular Degeneration (Dry-AMD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Gallbladder Cancer Market to Show Incremental Growth, estimates DelveInsight | P …
DelveInsight's "Gallbladder Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gallbladder Cancer, historical and forecasted epidemiology as well as the Gallbladder Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Gallbladder Cancer market report provides current treatment practices, emerging drugs, Gallbladder Cancer market share of the individual therapies, current and forecasted Gallbladder Cancer market Size from…
LAG-3-Next Generation Immunotherapy Market to Showcase Robust Growth in the Upco …
DelveInsight's "Lymphocyte Activation Gene-3 (LAG-3) Competitive Landscape and Market Forecast - 2035" report delivers an in-depth understanding of the LAG-3, historical and forecasted market trends of LAG-3 in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The report covers a descriptive overview including history, mechanism, principles, categories, advantages/ limitations of LAG-3 Next-generation Immunotherapies, and currently available therapies from 2019 to 2035 segmented by seven major markets.…
Renal Anemia Market to Show Incremental Growth During the Forecast Period | Prom …
DelveInsight's "Renal Anemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Renal Anemia, historical and forecasted epidemiology as well as the Renal Anemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Renal Anemia market report provides current treatment practices, emerging drugs, Renal Anemia market share of the individual therapies, current and forecasted Renal Anemia market Size…
